We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.07%
2 Financials 2.32%
3 Consumer Discretionary 2.2%
4 Healthcare 2.2%
5 Communication Services 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALPP
11951
CALL
DELISTED
Alpine 4 Holdings Inc
ALPP
$173K ﹤0.01%
+11,288
New +$251K
AEON.WS
11952
DELISTED
AEON Biopharma Inc
AEON.WS
$173K ﹤0.01%
340,219
-20,916
-6% -$11.6K
PHXM
11953
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$173K ﹤0.01%
7,333
+5,876
+403% +$198K
HGEN
11954
PUT
DELISTED
HUMANIGEN, INC.
HGEN
$173K ﹤0.01%
46,400
-35,400
-43% -$207K
NOVN
11955
PUT
DELISTED
Novan, Inc. Common Stock
NOVN
$173K ﹤0.01%
41,500
-16,800
-29% -$101K
COLIW
11956
DELISTED
Colicity Inc. Warrant
COLIW
$173K ﹤0.01%
224,999
+95,774
+74% +$88.4K
HTOO icon
11957
Fusion Fuel Green
HTOO
$17.3M
$172K ﹤0.01%
+595
New +$234K
INDI icon
11958
indie Semiconductor
INDI
$725M
$172K ﹤0.01%
14,405
+1,117
+8% +$14.2K
LFST icon
11959
PUT
Lifestance Health
LFST
$4.07B
$172K ﹤0.01%
18,100
-3,700
-17% -$39.2K
NGL icon
11960
CALL
NGL Energy Partners
NGL
$2.17B
$172K ﹤0.01%
94,500
+18,900
+25% +$42.2K
PKE icon
11961
CALL
Park Aerospace
PKE
$810M
$172K ﹤0.01%
13,000
-600
-4% -$8.06K
PLYA
11962
PUT
DELISTED
Playa Hotels & Resorts
PLYA
$172K ﹤0.01%
21,500
-20,300
-49% -$163K
SJT
11963
CALL
San Juan Basin Royalty Trust
SJT
$115M
$172K ﹤0.01%
28,300
+4,300
+18% +$27K
WSR
11964
PUT
DELISTED
Whitestone REIT
WSR
$172K ﹤0.01%
17,000
+3,300
+24% +$32.1K
RNLX
11965
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
$172K ﹤0.01%
+10,800
New +$216K
ARRWU
11966
DELISTED
Arrowroot Acquisition Corp. Unit
ARRWU
$172K ﹤0.01%
+17,198
New +$172K
RCOR.WS
11967
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$172K ﹤0.01%
301,410
-14
-0% -$9
AROC icon
11968
CALL
Archrock
AROC
$5.85B
$171K ﹤0.01%
22,800
+200
+0.9% +$1.61K
CLLS
11969
CALL
Cellectis
CLLS
$271M
$171K ﹤0.01%
21,100
+4,700
+29% +$46.2K
NGVC icon
11970
CALL
Vitamin Cottage Natural Grocers
NGVC
$748M
$171K ﹤0.01%
+12,000
New +$154K
SHO icon
11971
CALL
Sunstone Hotel Investors
SHO
$2.1B
$171K ﹤0.01%
14,600
+1,100
+8% +$13.2K
UROY
11972
CALL
Uranium Royalty Corp
UROY
$1.51B
$171K ﹤0.01%
+46,800
New +$213K
TVRD
11973
Tvardi Therapeutics
TVRD
$23.1M
$171K ﹤0.01%
390
-1,904
-83% -$957K
PGAL
11974
DELISTED
Global X MSCI Portugal ETF
PGAL
$171K ﹤0.01%
15,704
-3,485
-18% -$38.8K
PRPB
11975
CALL
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
$171K ﹤0.01%
17,300
-40,700
-70% -$402K

Similar funds

Citadel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Citadel Advisors held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Citadel Advisors's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Citadel Advisors added most to Amazon in Q4 2021, an estimated $802M increase.
  • Citadel Advisors's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Citadel Advisors fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Citadel Advisors's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Citadel Advisors opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Citadel Advisors's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.